S3842 Gene test hippel-lindau
Also known as: VHL gene test, von Hippel-Lindau testing
Genetic testing for mutations in the VHL tumor suppressor gene associated with von Hippel-Lindau disease and familial renal cell carcinoma.
In Plain Language
genetic test for kidney cancer risk; von Hippel-Lindau syndrome gene test
Clinical Context
Used in medical oncology and nephrology for screening of von Hippel-Lindau disease families and surveillance for associated malignancies.
RVU Information
CPT S3842 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
S-codes are used by private payers (not Medicare) for services without a standard CPT or HCPCS code. Coverage varies significantly between insurers. Verify payer acceptance before billing and document medical necessity thoroughly.
Specialties
Frequently Asked Questions
What is CPT code S3842?
CPT S3842 (Gene test hippel-lindau) is a S Codes code. Genetic testing for mutations in the VHL tumor suppressor gene associated with von Hippel-Lindau disease and familial renal cell carcinoma.
Is S3842 covered by insurance?
S3842 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used in medical oncology and nephrology for screening of von Hippel-Lindau disease families and surveillance for associated malignancies.
When is CPT S3842 used?
Used in medical oncology and nephrology for screening of von Hippel-Lindau disease families and surveillance for associated malignancies.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.